Sign in

CIK 0001469443

  • Non-accelerated filer
  • Smaller reporting company

Arcadia Biosciences, Inc.

Sign in to watch
Ticker
RKDA
Exchange
Nasdaq
Industry
Beverages
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810571538
Phone
+1 214-974-8921
Business address
5956 SHERRY LANE, SUITE 2000, DALLAS, TX
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Operating Officer sold 100 shares at $2.51 ($251)
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Open-market sale Interim Chief Financ. Officer sold 8,280 shares at $2.49 ($20,645)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Interim Chief Financ. Officer sold 1,720 shares at $2.42 ($4,169)
  9. 4 Open-market sale Chief Scientific Officer sold 2,853 shares at an average $2.98 ($8,499)
  10. 4 Open-market sale Chief Scientific Officer sold 3,273 shares at an average $3.20 ($10,476)
  11. 3/A Insider 3/A
  12. 4 Open-market sale Chief Scientific Officer sold 1,666 shares at $3.00 ($5,003)
  13. 4 Open-market sale President and CEO sold 3,200 shares at an average $2.92 ($9,350)
  14. 4 Open-market sale Interim Chief Financ. Officer sold 10,035 shares at $3.57 ($35,788)
  15. 3/A Insider 3/A
  16. 4 Open-market sale Chief Scientific Officer sold 15,000 shares at an average $4.01 ($60,134)
  17. 4 Open-market sale Chief Scientific Officer sold 4,527 shares at $2.91 ($13,191)
  18. 4 Exercise or conversion President and CEO acquired 3,000 shares (option exercise)
  19. 4 Open-market sale President and CEO sold 5,145 shares at $3.01 ($15,469)
  20. 4 Open-market sale President and CEO sold 9,100 shares at an average $3.13 ($28,440)

Page 8 of 11 · 203 filings